Breast Lesion Localization Methods Market To Reach $3.62 Billion By 2030

Breast Lesion Localization Methods Market Growth & Trends

The global breast lesion localization methods market size is anticipated to reach USD 3.62 billion by 2030 and is anticipated to grow at a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing government and non-government reimbursement policies for breast cancer diagnostics, biopsies, examinations, and related medical procedures are projected to drive adoption of breast lesion localization methods. Furthermore, the growing demand for improved healthcare infrastructure and facilities, driven by the rising prevalence of the disease among women, is anticipated to boost the market growth.

As the incidence of breast cancer among women rises, there is a heightened need for precise and early detection methods. Breast lesion localization techniques are pivotal in accurately identifying and targeting suspicious lesions for biopsy or surgical intervention. For instance, As per a report by National Breast Cancer Foundation, Inc., in April 2024, approximately 1 out of every 8 women in the U.S. will receive a breast cancer diagnosis during her lifetime. In 2024, it is projected that around 310,720 women and 2,800 men will be diagnosed with invasive breast cancer. With the increasing prevalence of breast cancer, there is a growing focus on tailored treatment strategies. Advanced lesion localization methods empower oncologists and surgeons to meticulously plan and deliver treatments, aiming for the best possible patient outcomes. These factors are driving the demand for breast lesions localizations methods.

Advancements in imaging technologies like digital mammography, ultrasound, and MRI have greatly improved the detection and characterization of breast lesions. As a result, there is an increased need for precise localization techniques to guide surgical procedures accurately. Furthermore, the integration of 3D imaging modalities and navigation systems allows surgeons to visualize breast lesion locations in real-time during procedures, significantly enhancing surgical precision and improving patient outcomes. These factors are propelling the market growth over the forecast period.

 Request a free sample copy or view report summary: Breast Lesion Localization Methods Market Report

Breast Lesion Localization Methods Market Report Highlights

• Based on type, the wire-guided localization segment held the largest market share in 2023 owing to the presence of a wide range of products and high adoption of this technique among end-users.

• Radioisotope localization is expected to witness significant growth over the forecast period as it is an effective, safe, and widely used procedure for preoperative localization of non-palpable, suspicious breast lesions.

• North America dominated the market with the highest revenue share in 2023 owing to the presence of key manufacturers in the region, established healthcare infrastructure, and high adoption of localization devices.

Breast Lesion Localization Methods Market Segmentation

Grand View Research has segmented the global breast lesion localization methods market based on type and region:

Breast Lesion Localization Methods Type Outlook (Revenue, USD Million, 2018 - 2030)

• Wire Guided Localization

• Radioisotope Localization

  • Radio guided occult-lesion localization (ROLL)

  • Radioactive-seed localization (RSL)

  • Others

• Magnetic Tracer

• Others

Breast Lesion Localization Methods Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Breast Lesion Localization Methods Market

• BD

• SOMATEX Medical Technologies GmbH

• Argon Medical Devices

• Merit Medical Systems

• Cook Medical

• STERYLAB S.r.l.

• Theragenics Corporation

• MDL SRL

• MOLLI Surgical